MBRX Moleculin Biotech, Inc.
NEUTRAL
Impact: 3/10
8-K
8-K context-dependent: Items 7.01
Latest settled — T+5d
MBRX ▲ +7.76% at T+5d
NEUTRAL call ✓ call won +7.76% · α vs SPY +6.67% · entry $2.45 → $2.64
Currently $2.40 · -2.04% from $2.45 entry
T+1d
+11.43%
call +11.43% · α +11.42%
$2.73
settled 9d ago
T+5d
+7.76%
call +7.76% · α +6.67%
$2.64
settled 3d ago
T+20d
—
call — · α —
—
in 19d
T+60d
—
call — · α —
—
in 3mo
Price Chart
Loading chart...
Executive Summary
Moleculin Biotech furnished a corporate investor presentation via an 8-K (Item 7.01). No new financial data, guidance, or material events were disclosed. The filing is a routine investor relations update.
Actionable Insight
This filing is a standard update with no immediate trading catalyst. Monitor upcoming clinical milestones or quarterly results for material developments.
Key Facts
- Company issued a corporate presentation as Exhibit 99.1, posted on its website.
- No financial results, guidance, or material developments were disclosed.
- Filing is under Regulation FD; information is furnished, not filed.
Financial Impact
No financial impact from this filing.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-018317 |
| Document: mbrx20260522c_8k.htm | 0001437749-26-018317 |
| Document: 0001437749-26-018317-index-headers.html | 0001437749-26-018317 |
| Document: 0001437749-26-018317-index.html | 0001437749-26-018317 |
| Document: 0001437749-26-018317.txt | 0001437749-26-018317 |
13 reports for MBRX
50%
Hit rate
best @ T+5▲ +9.81%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
today
|
8-K
| $2.55 awaiting T+5 | awaiting T+5 | — | $2.40 (−5.88%) |
|
May 29, 2026
7d ago
|
8-K
| $2.79 $2.46 | ▼ −11.83% | ▼ −11.54% | $2.40 (−13.98%) |
|
May 26, 2026
10d ago
|
8-K
| $2.45 $2.64 | ▲ +7.76% | ▲ +6.67% | $2.40 (−2.04%) |
|
May 22, 2026
14d ago
|
8-K
| $2.45 $2.64 | ▲ +7.76% | ▲ +6.67% | $2.40 (−2.04%) |
|
May 15, 2026
21d ago
|
8-K
| $2.11 $2.39 | ▲ +13.27% | ▲ +12.31% | $2.40 (+13.74%) |
|
May 15, 2026
21d ago
|
Press Release
| $2.11 $2.39 | ▼ −13.27% | ▼ −12.31% | $2.40 (−13.74%) |
|
May 13, 2026
23d ago
|
8-K
| $2.14 $2.35 | ▲ +9.81% | ▲ +10.97% | $2.40 (+12.15%) |
|
May 12, 2026
24d ago
|
8-K
| $2.34 $2.09 | ▼ −10.68% | ▼ −10.76% | $2.40 (+2.56%) |
|
May 8, 2026
28d ago
|
8-K
| $2.47 $2.20 | ▼ −10.93% | ▼ −12.39% | $2.40 (−2.83%) |
|
Apr 23, 2026
6w ago
|
8-K
| $2.54 $2.51 | ▼ −1.18% | ▼ −2.66% | $2.40 (−5.51%) |
Showing 10 of 13
US Market Status
Market Closed — Opens Mon (38h 7m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access